(1888PressRelease)
February 15, 2008 - Report Buyer, the online destination for business intelligence for major industry sectors, has now added a new report showing that new products and applications have made gene expression analysis a significantly more competitive market in the past few years, which will lead to a market worth nearly $2.5 billion by 2012.
“Gene Expression Profiling Markets” (http://www.reportbuyer.com/go/KAL00108) reports that real-time polymerase chain reaction (PCR), improvements in microarrays, and the increasing reality of clinical application beyond the research bench will propel double-digit growth in this segment for the next five years.
The new study finds that gene expression analysis has progressed significantly in the past two years with the emergence of a number of new techniques and technologies impacting the market, including next-generation sequencers, SNP analysis, copy number variation, methylation analysis, alternative splicing analysis, ChIP-on-chip, and micro RNA technology. In addition, better standardisation and compatibility among technologies and increasing clarity regarding regulatory issues are fueling healthy competition.
Authors of the report note that the perception that the Affymetrix platform is the only reliable, reproducible platform available is changing. They say customers thought they would never be able to compare legacy data with new data from other platforms; however, it has now been demonstrated that these fears are not justified, which has opened up the market to a host of new product introductions.
“Gene Expression Profiling Markets” provides market forecasts through 2012 for microarrays, instruments and reagents, as well as real-time PCR. It establishes competitive market share in gene expression analysis, segments revenues regionally, identifies market challenges, and discusses strategic recommendations for manufacturers. The study also reviews new technologies available and in development, recent business deals and alliances, progress on standardisation and regulatory guidance, and developments in new clinical applications just now emerging.
“Gene Expression Profiling Markets” is available from Report Buyer.
Report Buyer product ID: KAL00108
http://digbig.com/4rgca ###
